QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30

被引：0
|
作者：
M. T. King
D. S. J. Costa
N. K. Aaronson
J. E. Brazier
D. F. Cella
P. M. Fayers
P. Grimison
M. Janda
G. Kemmler
R. Norman
A. S. Pickard
D. Rowen
G. Velikova
T. A. Young
R. Viney
机构：
[1] University of Sydney,Psycho
[2] University of Sydney,Oncology Cooperative Research Group (PoCoG), School of Psychology, Faculty of Science
[3] The Netherlands Cancer Institute,Central Clinical School, Sydney Medical School, Faculty of Medicine
[4] University of Sheffield,Division of Psychosocial Research & Epidemiology
[5] Northwestern University,Health Economics and Decision Science, School of Health and Related Research
[6] University of Aberdeen,Department of Medical Social Sciences, Feinberg School of Medicine
[7] Norwegian University of Science and Technology (NTNU),Institute of Applied Health Sciences
[8] University of Sydney,Department of Cancer Research and Molecular Medicine
[9] Queensland University of Technology,Chris O’Brien Lifehouse, Sydney Medical School
[10] Innsbruck Medical University,School of Public Health, Institute of Health and Biomedical Innovation
[11] Curtin University,Department of Psychiatry and Psychotherapy
[12] University of Technology Sydney (UTS),School of Public Health
[13] University of Illinois at Chicago,Centre for Health Economics Research and Evaluation (CHERE)
[14] University of Leeds,Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy
[15] St James’s University Hospital,Leeds Institute of Cancer and Pathology
来源：
Quality of Life Research | 2016年 / 25卷
关键词：
Quality of life; Utility; QLQ-C30; Multi-attribute utility instrument; Cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：625 / 636
页数：11
相关论文
共 50 条
  • [21] Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D
    Femke Jansen
    Irma M. Verdonck-de Leeuw
    Eva Gamper
    Richard Norman
    Bernhard Holzner
    Madeleine King
    Georg Kemmler
    Quality of Life Research, 2021, 30 : 2009 - 2019
  • [22] Comparison of German, French and Polish utility weights for the EORTC utility instrument QLU-C10D
    Kemmler, Georg
    Gamper, Eva
    Nerich, Virginie
    King, Madeleine
    Norman, Richard
    Holzner, Bernhard
    QUALITY OF LIFE RESEARCH, 2016, 25 : 76 - 76
  • [23] Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D
    Jansen, Femke
    Verdonck-de Leeuw, Irma M.
    Gamper, Eva
    Norman, Richard
    Holzner, Bernhard
    King, Madeleine
    Kemmler, Georg
    QUALITY OF LIFE RESEARCH, 2021, 30 (07) : 2009 - 2019
  • [24] Chinese utility weights for the EORTC cancer-specific utility instrument QLU-C10D
    Cao, Yiyin
    Xu, Juan
    Norman, Richard
    King, Madeleine T.
    Kemmler, Georg
    Huang, Weidong
    Luo, Nan
    QUALITY OF LIFE RESEARCH, 2024, 33 (12) : 3335 - 3349
  • [25] Utility weights for the EORTC QLU-C10D for Spain and investigation of a potential "Corona effect"
    Kemmler, Georg
    Lehmann, Jens
    von Butler, Ludwig
    Ansari, Shaad
    Norman, Richard
    King, Madeleine
    Holzner, Bernhard
    QUALITY OF LIFE RESEARCH, 2020, 29 (SUPPL 1) : S36 - S36
  • [26] The EORTC QLU-C10D utility project - interim evaluation and comparison across countries
    Kemmler, Georg
    Gamper, Eva
    King, Madeleine T.
    Norman, Richard
    Nerich, Virginie
    Holzner, Bernhard
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 32 - 33
  • [27] Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score
    Klapproth, Christoph Paul
    Fischer, Felix
    Rose, Matthias
    Karsten, Maria Margarete
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 152 : 101 - 109
  • [28] ESTIMATING EORTC-8D HEALTH STATE UTILITY VALUES FROM EORTC QLQ-C30 SCORES IN RELAPSED MULTIPLE MYELOMA
    Ashaye, A. O.
    Altincatal, A.
    Bender, R. H.
    Zhang, J.
    Panjabi, S.
    VALUE IN HEALTH, 2015, 18 (07) : A468 - A468
  • [29] The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands
    Pilz, Micha J.
    Seyringer, Simon
    Hallsson, Lara R.
    Bottomley, Andrew
    Jansen, Femke
    King, Madeleine T.
    Norman, Richard
    Rutten, Marianne J.
    Verdonck-de Leeuw, Irma M.
    Siersema, Peter D.
    Gamper, Eva Maria
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (09): : 1539 - 1555
  • [30] Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma
    Seyringer, Simone
    Pilz, Micha J.
    Bottomley, Andrew
    King, Madeleine T.
    Norman, Richard
    Gamper, Eva M.
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024,
12345